These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

742 related articles for article (PubMed ID: 7525853)

  • 1. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.
    Strassmann G; Patil-Koota V; Finkelman F; Fong M; Kambayashi T
    J Exp Med; 1994 Dec; 180(6):2365-70. PubMed ID: 7525853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 does not mediate the inhibitory effect of PDE-4 inhibitors and other cAMP-elevating drugs on lipopolysaccharide-induced tumors necrosis factor-alpha generation from human peripheral blood monocytes.
    Seldon PM; Barnes PJ; Giembycz MA
    Cell Biochem Biophys; 1998; 29(1-2):179-201. PubMed ID: 9631245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of protein kinases in the potentiation of lipopolysaccharide-induced inflammatory mediator formation by thapsigargin in peritoneal macrophages.
    Chen BC; Hsieh SL; Lin WW
    J Leukoc Biol; 2001 Feb; 69(2):280-8. PubMed ID: 11272279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenaline suppression of the macrophage nitric oxide response to lipopolysaccharide is associated with differential regulation of tumour necrosis factor-alpha and interleukin-10.
    Zinyama RB; Bancroft GJ; Sigola LB
    Immunology; 2001 Dec; 104(4):439-46. PubMed ID: 11899430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-4 and IL-13 modulate IL-10 release in endotoxin-stimulated murine peritoneal mononuclear phagocytes.
    Kambayashi T; Jacob CO; Strassmann G
    Cell Immunol; 1996 Jul; 171(1):153-8. PubMed ID: 8660851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10.
    Kambayashi T; Alexander HR; Fong M; Strassmann G
    J Immunol; 1995 Apr; 154(7):3383-90. PubMed ID: 7897221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of cAMP-elevating agents and glucocorticoid either alone or in combination on the production of nitric oxide, interleukin-12 and interleukin-10 in IFN-gamma- and LPS-activated mouse peritoneal macrophages.
    Mittal J; Dogra N; Dass R; Majumdar S
    Folia Microbiol (Praha); 2002; 47(6):709-16. PubMed ID: 12630324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human interleukin 10 suppresses production of inflammatory mediators by LPS-stimulated equine peritoneal macrophages.
    Hawkins DL; MacKay RJ; MacKay SL; Moldawer LL
    Vet Immunol Immunopathol; 1998 Nov; 66(1):1-10. PubMed ID: 9847016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo therapeutics of β-thujaplicin on LPS-induced inflammation in macrophages and septic shock in mice.
    Shih MF; Chen LY; Tsai PJ; Cherng JY
    Int J Immunopathol Pharmacol; 2012; 25(1):39-48. PubMed ID: 22507316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic induction of IL-10 by hypertonic saline solution and lipopolysaccharides in murine peritoneal macrophages.
    Oreopoulos GD; Bradwell S; Lu Z; Fan J; Khadaroo R; Marshall JC; Li YH; Rotstein OD
    Surgery; 2001 Aug; 130(2):157-65. PubMed ID: 11490344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation.
    Berlato C; Cassatella MA; Kinjyo I; Gatto L; Yoshimura A; Bazzoni F
    J Immunol; 2002 Jun; 168(12):6404-11. PubMed ID: 12055259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication.
    Pope M; Rotstein O; Cole E; Sinclair S; Parr R; Cruz B; Fingerote R; Chung S; Gorczynski R; Fung L
    J Virol; 1995 Sep; 69(9):5252-60. PubMed ID: 7636967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production.
    Trepicchio WL; Bozza M; Pedneault G; Dorner AJ
    J Immunol; 1996 Oct; 157(8):3627-34. PubMed ID: 8871663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal glycocalyx activates macrophage prostaglandin E2 and interleukin 1 production and modulates tumor necrosis factor alpha and nitric oxide production.
    Stout RD; Li Y; Miller AR; Lambe DW
    Infect Immun; 1994 Oct; 62(10):4160-6. PubMed ID: 7927671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of IL 6, IL 1 A, IL 1 beta and TNF alpha production in LPS-stimulated human monocytes: role of cyclic AMP.
    Bailly S; Ferrua B; Fay M; Gougerot-Pocidalo MA
    Cytokine; 1990 May; 2(3):205-10. PubMed ID: 1716487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity.
    Ding AH; Nathan CF
    J Immunol; 1987 Sep; 139(6):1971-7. PubMed ID: 3040860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate inhibits LPS-induced tumor necrosis factor production in vivo.
    Durez P; Appelboom T; Vray B; Pira C; Goldman M
    Eur Cytokine Netw; 1998 Dec; 9(4):669-72. PubMed ID: 9889412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geniposide suppresses LPS-induced nitric oxide, PGE2 and inflammatory cytokine by downregulating NF-κB, MAPK and AP-1 signaling pathways in macrophages.
    Shi Q; Cao J; Fang L; Zhao H; Liu Z; Ran J; Zheng X; Li X; Zhou Y; Ge D; Zhang H; Wang L; Ran Y; Fu J
    Int Immunopharmacol; 2014 Jun; 20(2):298-306. PubMed ID: 24735815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.